Avalo Therapeutics Shares Financial Results and Strategic Developments for 2024
March 20, 2025 - 10:26
Avalo Therapeutics has announced its financial results for 2024, highlighting significant updates regarding its ongoing clinical trials and organizational changes. The company is eagerly anticipating topline data from the Phase 2 LOTUS Trial of AVTX-009, which is being investigated for the treatment of hidradenitis suppurativa. This crucial data is expected to be released in 2026, marking an important milestone in Avalo's research and development efforts.
In a strategic move to bolster its leadership team, Avalo has appointed Jennifer Riley as the Chief Strategy Officer. Her expertise is expected to enhance the company's strategic direction as it navigates the complex landscape of biotechnology.
As of December 31, 2024, Avalo reported having approximately $135 million in cash reserves. This financial position is projected to provide sufficient runway into at least 2027, allowing the company to continue its focus on advancing innovative treatments for immune dysregulation.
MORE NEWS
February 21, 2026 - 03:39
Supreme Court Justices Affirm Legality of Trump-Era TariffsIn a significant legal opinion, three U.S. Supreme Court justices have stated that tariffs imposed during the Trump administration were lawful. Justices Brett Kavanaugh, Samuel Alito, and Clarence...
February 20, 2026 - 02:56
Calpine Business UnitA major consolidation within the Calpine Corporation is set to reshape the American power landscape. The company has announced the merger of its primary business units, a strategic move designed to...
February 19, 2026 - 21:58
High-income shoppers boost Walmart's e-commerce businessWalmart is successfully attracting a new wave of customers: high-income households. The retail giant reports a significant and steady gain in market share from shoppers earning over $100,000...
February 19, 2026 - 03:17
San Francisco announces $6.3 million in grants for small businessesIn a significant move to fortify its local economy, San Francisco has unveiled a substantial $6.3 million grant program aimed directly at supporting its small business community. The initiative,...